AKT1 and non-small cell lung carcinoma: KEGG pathway enrichment analysis showed that the targets of the core active components of IPTF were highly significantly enriched in key signaling pathways such as the PI3K-AKT signaling pathway (p = 1.96 × 10−20) and the non-small cell lung cancer pathway (p = 1.26 × 10−22).